| Primary information |
|---|
| ID | antitb_1817, |
| Name | 23173767 |
| N-Terminal modification | Ub2scr |
| C-Terminal Modification | RLGRLVSLHTLG |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 12 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Strain | Analogue of Ub2 |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis mc2156 |
| Cell Line | MIC > 400 μM |
| Inhibition Concentration | In vitro |
| Sequence | 2012 |
| Cytotoxicity | None |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Micellar aggregate channel model |
| Other activities | Cytoplasmic membrane |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |